NEKTAR THERAPEUTICS — Director's Dealing 2015

Dec 7, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2015-12-04

Reporting Person: KUEBLER CHRISTOPHER A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-04	Common Stock	M	15000	$5.15	Acquired	35000	Direct
2015-12-04	Common Stock	S	15000	$15.82	Disposed	20000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-04	Stock Option	$5.15	M	15000	Disposed	2016-12-01	Common Stock (15000)	Direct

Footnotes

F1: This transaction involved a stock option scheduled to expire in 2016.